Connect Biopharma Holdings (CNTB)
(Delayed Data from NSDQ)
$1.57 USD
-0.04 (-2.48%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.57 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
CNTB 1.57 -0.04(-2.48%)
Will CNTB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CNTB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CNTB
What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now?
CNTB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for CNTB
CNTB falls 2.48% on September 19, leaving the technical picture intact
Is CNTB about to break its pattern? NR7 shows up after a flat session
Stochastic Buy Signal appears for CNTB after 0.0% move
CNTB's price rises by 0.63% on September 16, though its technical setup remains stable.
Connect Biopharma Executives Increase Share Holdings